Federated Hermes’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.79M | Buy |
456,319
+21,545
| +5% | +$223K | 0.01% | 848 |
|
|
2025
Q4 | $5.37M | Buy |
434,774
+33,516
| +8% | +$359K | 0.01% | 770 |
|
|
2025
Q3 | $3.54M | Buy |
401,258
+121,789
| +44% | +$947K | 0.01% | 806 |
|
|
2025
Q2 | $1.78M | Buy |
279,469
+328
| +0.1% | +$1.88K | ﹤0.01% | 970 |
|
|
2025
Q1 | $1.36M | Buy |
279,141
+1,331
| +0.5% | +$11K | ﹤0.01% | 1033 |
|
|
2024
Q4 | $2.66M | Buy |
277,810
+6,058
| +2% | +$55.6K | 0.01% | 870 |
|
|
2024
Q3 | $2.27M | Sell |
271,752
-1,535
| -0.6% | -$14K | 0.01% | 900 |
|
|
2024
Q2 | $1.86M | Buy |
273,287
+253,960
| +1,314% | +$1.09M | ﹤0.01% | 940 |
|
|
2024
Q1 | $48.9K | Sell |
19,327
-2,101
| -10% | -$4.74K | ﹤0.01% | 1621 |
|
|
2023
Q4 | $51.4K | Sell |
21,428
-183,401
| -90% | -$431K | ﹤0.01% | 1643 |
|
|
2023
Q3 | $696K | Sell |
204,829
-46,672
| -19% | -$259K | ﹤0.01% | 1241 |
|
|
2023
Q2 | $1.85M | Sell |
251,501
-444,230
| -64% | -$4.12M | ﹤0.01% | 981 |
|
|
2023
Q1 | $7.21M | Buy |
695,731
+21,691
| +3% | +$262K | 0.02% | 621 |
|
|
2022
Q4 | $7.96M | Buy |
674,040
+271,342
| +67% | +$4.2M | 0.02% | 596 |
|
|
2022
Q3 | $8.45M | Buy |
402,698
+380,668
| +1,728% | +$10.6M | 0.02% | 563 |
|
|
2022
Q2 | $684K | Sell |
22,030
-276,178
| -93% | -$9.43M | ﹤0.01% | 1278 |
|
|
2022
Q1 | $12.2M | Buy |
298,208
+297,551
| +45,289% | +$13.1M | 0.03% | 555 |
|
|
2021
Q4 | $29K | Sell |
657
-140,415
| -100% | -$6.35M | ﹤0.01% | 1844 |
|
|
2021
Q3 | $7.06M | Sell |
141,072
-4,290
| -3% | -$260K | 0.01% | 742 |
|
|
2021
Q2 | $9.16M | Sell |
145,362
-99,328
| -41% | -$6.38M | 0.02% | 689 |
|
|
2021
Q1 | $22.7M | Buy |
244,690
+13,835
| +6% | +$1.42M | 0.04% | 457 |
|
|
2020
Q4 | $20.7M | Buy |
230,855
+50,628
| +28% | +$4.65M | 0.04% | 461 |
|
|
2020
Q3 | $18.6M | Buy |
180,227
+38,611
| +27% | +$4.16M | 0.04% | 425 |
|
|
2020
Q2 | $11.2M | Sell |
141,616
-73,746
| -34% | -$5.5M | 0.03% | 519 |
|
|
2020
Q1 | $12.5M | Sell |
215,362
-42,798
| -17% | -$2.47M | 0.04% | 433 |
|
|
2019
Q4 | $13.9M | Sell |
258,160
-31,500
| -11% | -$1.71M | 0.03% | 520 |
|
|
2019
Q3 | $15.1M | Buy |
289,660
+19,108
| +7% | +$890K | 0.04% | 435 |
|
|
2019
Q2 | $13.1M | Buy |
270,552
+33,611
| +14% | +$1.61M | 0.03% | 486 |
|
|
2019
Q1 | $12M | Buy |
236,941
+1,228
| +0.5% | +$72.4K | 0.03% | 497 |
|
|
2018
Q4 | $14M | Buy |
235,713
+16,253
| +7% | +$1.05M | 0.04% | 394 |
|
|
2018
Q3 | $14.4M | Buy |
219,460
+50,980
| +30% | +$2.97M | 0.03% | 448 |
|
|
2018
Q2 | $8.51M | Sell |
168,480
-138,856
| -45% | -$7.23M | 0.03% | 515 |
|
|
2018
Q1 | $16.2M | Sell |
307,336
-183,505
| -37% | -$9.15M | 0.05% | 297 |
|
|
2017
Q4 | $22.8M | Buy |
490,841
+262,729
| +115% | +$11.1M | 0.06% | 229 |
|
|
2017
Q3 | $9.23M | Sell |
228,112
-16,890
| -7% | -$611K | 0.03% | 410 |
|
|
2017
Q2 | $8.31M | Buy |
245,002
+8,098
| +3% | +$250K | 0.02% | 440 |
|
|
2017
Q1 | $6.88M | Sell |
236,904
-3,897
| -2% | -$119K | 0.02% | 498 |
|
|
2016
Q4 | $7.91M | Sell |
240,801
-44,075
| -15% | -$1.32M | 0.02% | 451 |
|
|
2016
Q3 | $8.98M | Buy |
284,876
+79,138
| +38% | +$2.3M | 0.03% | 454 |
|
|
2016
Q2 | $5.79M | Sell |
205,738
-20,742
| -9% | -$813K | 0.02% | 513 |
|
|
2016
Q1 | $8.23M | Buy |
226,480
+3,011
| +1% | +$106K | 0.03% | 449 |
|
|
2015
Q4 | $8.94M | Buy |
223,469
+210,524
| +1,626% | +$7.34M | 0.03% | 460 |
|
|
2015
Q3 | $369K | Buy |
+12,945
| New | +$427K | ﹤0.01% | 1368 |
|
Other funds holding EBS
VCM
PCM
VPM